Gland Pharma Limited
FDA inspection history in Anakapalli District, India, 2025
- 1
- Form 483
Every document, by year
- Form 483
2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2025One Form 483, at Anakapalli District, India.
Cited most
Across all Gland Pharma Limited observations on file
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.42Design and construction features1
The complete Gland Pharma Limited file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Anakapalli District, India
One Form 483 · 2025 · 3 observations
Latest: Form 483, Feb 25, 2025 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-02-25 | 483 Form 483 | Anakapalli District, India | 3 | $99 |
FEI number 3010142300 · most recent document Feb 25, 2025
About Gland Pharma Limited
How many FDA Form 483s has Gland Pharma Limited received?
FDA Intel has 1 Form 483 on file for Gland Pharma Limited; the most recent is dated Feb 25, 2025.
When was Gland Pharma Limited last inspected by FDA?
The most recent FDA inspection document on file for Gland Pharma Limited is a Form 483 dated Feb 25, 2025, for the site in Anakapalli District, India.
What did FDA cite at Gland Pharma Limited?
The regulations cited most in the observations on file for Gland Pharma Limited are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.42 (Design and construction features), 1 time.